Completed PHASE3 INTERVENTIONAL 2-arm NCT02564276

Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Interventions Sentinel lymph node biopsy

Updated 8 times since 2017 Last updated: Jan 23, 2018 Started: Feb 29, 2016 Primary completion: Apr 30, 2017 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02564276, this PHASE3 trial focuses on Endometrial Neoplasms and remains completed. Sponsored by Centre hospitalier de l'Université de Montréal (CHUM), it has been updated 8 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Feb 2018 — Jun 2018 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Feb 2017 — Feb 2018 [monthly]

Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre hospitalier de l'Université de Montréal (CHUM)

Data source: Centre hospitalier de l'Université de Montréal (CHUM)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada